Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,995 public trials 744 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms

NCT00497523

Conditions
Asthma, Bronchial Asthma, Bronchial Diseases, +7 more
Locations
  • Zaklad Alergologii Dzieciecej Bialystok, Poland
  • Specjalistyczne Centrum Leczenia Dzieci i Mlodziezy Krakow, Poland
  • Wojskovy Szpital Klinikzny Krakow, Poland
  • Priwatna Pomoc Lekarska Lodz, Poland
View all 19 locations
View Trial Details
Completed

Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)

NCT00413387

Conditions
Asthma, Bronchial Asthma, Bronchial Diseases, +7 more
Locations
  • Ambulance For Paediatric and Pulmonology Vienna, Austria
  • Nzoz "Medex"Poradnia Alergologiczna Bielsko-Biala, Poland
  • Centrum Uslug Medycznych Krakow, Poland
  • Centrum Alergologii Lodz, Poland
View all 13 locations
View Trial Details
Completed

As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma

NCT00382889

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Ambulance for pediatrics and Pneumology Vienna, Austria
  • Pulmologisches Zentrum Der Stadt Wien Vienna, Austria
  • Dip. di Pneumologia - Osp. Tommaselli Catania, Italy
  • Nuove Cliniche Arcispedale S.Anna Ferrara, Italy
View all 25 locations
View Trial Details
Completed

EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI

NCT00394368

Conditions
Asthma, Bronchial Asthma, Bronchial Diseases, +7 more
Locations
  • Nzoz "Non nocere" Gdansk, Poland
  • Outpatients Department of Allergology "Medcare" Gdansk, Poland
  • Nzoz "Krakow Poludnie" Pulmonologic Policlinic Krakow, Poland
  • Specialist Allergy Center All-Med Krakow, Poland
View Trial Details
Completed

Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD

NCT02680197

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Clinical Trial Site 203-002 Karlovy Vary, Czechia
  • Clinical Trial Site 203-003 Kralupy nad Vltavou, Czechia
  • Clinical Trial Site 203-001 Mělník, Czechia
  • Clinical Trial Site 203-007 Mladá Boleslav, Czechia
View all 30 locations
View Trial Details

Related conditions